Beyond GOG-258 and PORTEC-3: a national cancer database analysis of adjuvant therapy for improved survival in high-risk endometrial cancer

被引：0
|
作者：
Lander, Megan [1 ]
Vargo, John [1 ]
Sukumvanich, Paniti [1 ]
机构：
[1] Univ Pittsburgh, Gynecol Oncol, Magee Womens Hosp, Med Ctr, Pittsburgh, PA USA
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_3期
关键词：
D O I：
10.1136/ijgc-2024-IGCS.252
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EV133/#547
引用
收藏
页码：A154 / A154
页数：1
相关论文
共 50 条
  • [1] Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: Impact on adjuvant therapy
    Creutzberg, C. L.
    Leon-Castillo, A.
    de Boer, S. M.
    Powell, M. E.
    Mileshkin, L. R.
    Mackay, H. J.
    Leary, A.
    Nijman, H. W.
    Singh, N.
    Pollock, P.
    Fyles, A.
    Haie-Meder, C.
    Smit, V. T. H. B. M.
    Edmondson, R. J.
    Putter, H.
    Kitchener, H. C.
    Crosbie, E. J.
    de Bruyn, M.
    Nout, R.
    Bosse, T.
    ANNALS OF ONCOLOGY, 2019, 30 : 899 - +
  • [2] Ten-year results of the PORTEC-3 trial: adjuvant therapy for women with high-risk endometrial cancer
    Post, Cathalijne C. B.
    de Boer, Stephanie M.
    Powell, Melanie E.
    Mileshkin, Linda
    Katsaros, Dionyssios
    Bessette, Paul
    Leary, Alexandra
    Ottevanger, Nelleke P.
    McCormack, Mary
    Khaw, Pearly
    D'Amico, Romerai
    Fyles, Anthony
    Chargari, Cyrus
    Kitchener, Henry C.
    Nijman, Hans W.
    Lutgens, Ludy
    Jurgenliemk-Schulz, Ina M.
    Nout, Remi A.
    Putter, Hein
    Horeweg, Nanda
    Bosse, Tjalling
    Creutzberg, Carien L.
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1122 - S1124
  • [3] Patterns of Recurrence and Survival in the Randomized Portec-3 Trial of Chemoradiotherapy for High-Risk Endometrial Cancer
    de Boer, S.
    Powell, M. E.
    Mileshkin, L.
    Katsaros, D.
    Bessette, P.
    Haie-Meder, C.
    Ottevanger, P. B.
    Ledermann, J. A.
    Khaw, P.
    Colombo, A.
    Fyles, A.
    Baron, M. H.
    Jurgenliemk-Schulz, I.
    Kitchener, H.
    Nijman, H. W.
    Kruitwagen, R. F.
    Smit, V. T.
    Nout, R. A.
    Putter, H.
    Creutzberg, C. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S1 - S2
  • [4] Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy
    Leon-Castillo, Alicia
    de Boer, Stephanie M.
    Powell, Melanie E.
    Mileshkin, Linda R.
    Mackay, Helen J.
    Leary, Alexandra
    Nijman, Hans W.
    Singh, Naveena
    Pollock, Pamela M.
    Bessette, Paul
    Fyles, Anthony
    Haie-Meder, Christine
    Smit, Vincent T. H. B. M.
    Edmondson, Richard J.
    Putter, Hein
    Kitchener, Henry C.
    Crosbie, Emma J.
    de Bruyn, Marco
    Nout, Remi A.
    Horeweg, Nanda
    Creutzberg, Carien L.
    Bosse, Tjalling
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (29) : 3388 - +
  • [5] The PORTEC-3 trial for high-risk endometrial cancer: impact of molecular classification on prognosis and benefit from adjuvant therapy
    Marnitz, Simone
    Schoemig-Markiefka, Birgid
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (03) : 266 - 268
  • [6] Clinical Implications of the PORTEC-3 Trial for the Treatment of High-Risk Endometrial Cancer
    Waltar, Till
    Marnitz, Simone
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (04) : 410 - 413
  • [7] PROGNOSTIC RELEVANCE OF THE MOLECULAR CLASSIFICATION IN HIGH-RISK ENDOMETRIAL CANCER: ANALYSIS OF THE PORTEC-3 TRIAL
    Leon-Castillo, A.
    de Boer, S. M.
    Powell, M. E.
    Mileshkin, L. R.
    Mackay, H. J.
    Leary, A.
    Nijman, H. W.
    Singh, N.
    Pollock, P.
    Bessette, P.
    Haie-Meder, C.
    Smit, V. T. H. B. M.
    Edmondson, R. J.
    Putter, H.
    Kitchener, H. C.
    Crosbie, E. J.
    de Bruyn, M.
    Nout, R. A.
    Horeweg, N.
    Bosse, T.
    Creutzberg, C. L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A7 - A8
  • [8] Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer
    de Boer, S. M.
    Wortman, B. G.
    Bosse, T.
    Powell, M. E.
    Singh, N.
    Hollema, H.
    Wilson, G.
    Chowdhury, M. N.
    Mileshkin, L.
    Pyman, J.
    Katsaros, D.
    Carinelli, S.
    Fyles, A.
    McLachlin, C. M.
    Haie-Meder, C.
    Duvillard, P.
    Nout, R. A.
    Verhoeven-Adema, K. W.
    Putter, H.
    Creutzberg, C. L.
    Smit, V. T. H. B. M.
    ANNALS OF ONCOLOGY, 2018, 29 (02) : 424 - 430
  • [9] Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
    de Boer, Stephanie M.
    Powell, Melanie E.
    Mileshkin, Linda
    Katsaros, Dionyssios
    Bessette, Paul
    Haie-Meder, Christine
    Ottevanger, Petronella B.
    Ledermann, Jonathan A.
    Khaw, Pearly
    D'Amico, Romerai
    Fyles, Anthony
    Baron, Marie-Helene
    Jurgenliemk-Schulz, Ina M.
    Kitchener, Henry C.
    Nijman, Hans W.
    Wilson, Godfrey
    Brooks, Susan
    Gribaudo, Sergio
    Provencher, Diane
    Hanzen, Chantal
    Kruitwagen, Roy F.
    Smit, Vincent T. H. B. M.
    Singh, Naveena
    Do, Viet
    Lissoni, Andrea
    Nout, Remi A.
    Feeney, Amanda
    Verhoeven-Adema, Karen W.
    Putter, Hein
    Creutzberg, Carien L.
    LANCET ONCOLOGY, 2019, 20 (09): : 1273 - 1285
  • [10] Final results of the international randomized PORTEC-3 trial of adjuvant chemotherapy and radiation therapy (RT) versus RT alone for women with high-risk endometrial cancer
    de Boer, Stephanie M.
    Powell, Melanie E.
    Mileshkin, Linda R.
    Katsaros, Dionyssios
    Bessette, Paul
    Haie-Meder, Christine
    Ottevanger, Petronella B.
    Ledermann, Jonathan A.
    Khaw, Pearly
    Colombo, Alessandro
    Fyles, Anthony W.
    Baron, Marie-Helene
    Kitchener, Henry C.
    Nijman, Hans
    Kruitwagen, Roy F. P. M.
    Jurgenliemk-Schulz, Ina M.
    Nout, Remi A.
    Smit, Vincent T. H. B. M.
    Putter, Hein
    Creutzberg, Carien L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345